Skip to main content
SpringerLink
Log in

Contralateral prophylactic mastectomy in women with breast cancer without a family history or genetic predisposition

Consensus statement from the Austrian Gynecologic Oncology Working Group of the Austrian Society of Obstetrics and Gynecology

  • consensus statement
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Summary

The working group recommends against contralateral prophylactic mastectomy (CPM) in women with breast cancer without a family history or genetic predisposition with unilateral breast cancer. This is based on the low risk of developing contralateral breast cancer, the lack of a survival benefit, the increased risk of surgical complications, and the lack of benefit on quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Notes

  1. Bilateral breast cancer counts for two cases of breast cancer.

  2. Bilateral breast cancer counts for two cases of breast cancer.

  3. This recommendation is also pertinent to patients with cancer of the fallopian tube and primary peritoneal cancer.

References

  1. Boughey JC, Attai DJ, Chen SL, et al. Contralateral prophylactic mastectomy (CPM) consensus statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks. Ann Surg Oncol. 2016;23:3100–5.

    Article  Google Scholar 

  2. Pesce CE, Liederbach E, Czechura T, et al. Changig surgical trends in young patients with early stage breast cancer, 2003–2010: A report from the National Cancer Data base. J Am Coll Surg. 2014;219:19–30.

    Article  Google Scholar 

  3. Singer CF, Tea MK, Pristauz G, et al. Clinical Practice Guideline for the prevention and early detection of breast and ovarian cancer in women from HBOC (hereditary breast and ovarian cancer) families. Wien Klin Wochenschr. 2015;127:981–6.

    Article  CAS  Google Scholar 

  4. Schmutzler RK. Consensus recommendation of the German consortium on familial breast and ovarian cancer to deal with the results of the multigene analysis. Geburtshilfe Frauenheilkd. 2017;77(07):733–9. https://doi.org/10.1055/s-0043-108531.

    Article  Google Scholar 

  5. NCCN. NCCN guidelines; version 2.2019; Genetik/Familian high risk assessment: Breast and ovarian. 2018. https://www.nccn.org/about/news/ebulletin/ebulletindetail.aspx?ebulletinid=1476..

    Google Scholar 

  6. DGGG, DKG. Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer. Stuttgart: Thieme; 2018. Guideline of the DGGG and the DKG (S3-Level), AWMF Registry Number 032/045OL, December 2017.

    Google Scholar 

  7. Arbeitsgemeinschaft Gynäkologische Onkologie. Startseite. 2019. http://www.ago-online.de/de/start/..

    Google Scholar 

  8. Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evvaluation of the contralatral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356:1295–303.

    Article  CAS  Google Scholar 

  9. Andersopn K, Jacobson JS, Heitjan DF, et al. Cost-effectiveness of preventive strategies for women with a BRCA 1 or a BRCA2 mutation. Ann Intern Med. 2006;144:397–406.

    Article  Google Scholar 

  10. Early Breast Cancer Trialists’Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randmosed trials. Lancet. 2005;365:1687–1617.

    Article  Google Scholar 

  11. Reiner AS, John EM, Brooks JD, et al. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA 1 and BRCA 2 utations with a family history of breast cancer: A report from the Women’s Enviromental Caner and Radiation Epidemiology Study. J Clin Oncol. 2013;31:433–9.

    Article  Google Scholar 

  12. Early Breast Cancer Trialists’Collaborative Group (EBCTCG), Davies C, Godwin J, Gray R, et al. Relevance of breast cancer hormone receptors and other factord to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials. Lancet. 2011;378:771–84.

    Article  Google Scholar 

  13. Carbine NE, Lostumbo L, Wallace J, Ko H. Risk-reducing mastectomy for the prevention of primary breastcancer. Cochrane Database Syst Rev. 2018; https://doi.org/10.1002/14651858.cd002748.pub4.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Bedrosian I, Hu CY, Chang GJ. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst. 2010;102(6):401–9.

    Article  Google Scholar 

  15. Jatoi I, Parsons HM. Contralateral prophylactic mastectomy and its association with reduced mortality: Evidence for selection bias. Breast Cancer Res Treat. 2014;148(2):389–96. https://doi.org/10.1007/s10549-014-3160-y.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Zeichner SB, Zeichner SB, Ruiz AL, et al. Improvedlong-term survivalwith contralateral prophylactic mastectomy among young women. Asian Pac J Cancer Prev. 2014;15(3):1155–62.

    Article  Google Scholar 

  17. Zion SM, Slezak JM, Sellers TA, et al. Reoperations after prophylactic mastectomy with or without implant reconstruction. Cancer. 2003;98:2152–60.

    Article  Google Scholar 

  18. Miller ME, Czechura T, Martz B, et al. Operative risks associated with contralateral prophylactic mastectomy: A single institution experience. Ann Surg Oncol. 2013;20:4113–20.

    Article  Google Scholar 

  19. Silva AK, Lapin B, Yao KA, et al. The effect of contralateral prophylactic mastectomy on perioperative complications in women undergoing immediate breast reconstruction: A NSQIP analysis. Ann Surg Oncol. 2015;22:3474–80.

    Article  Google Scholar 

  20. Osman F, Saleh F, Jackson TD, et al. Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: An analysis of the NSQIP database. Ann Surg Oncol. 2013;20:3212–7.

    Article  Google Scholar 

  21. Sharpe SM, Liederbach E, Czechura T, et al. Impact of bilateral versus unilateral mastectomy on short term outcomes and adjuvant therapy, 2003–2010: A report from the National Cancer Data Base. Ann Surg Oncol. 2014;21:2920–7.

    Article  Google Scholar 

  22. Koslow S, Pharmer LA, Scott AM, et al. Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction. Ann Surg Oncol. 2013;20:3422–9.

    Article  Google Scholar 

  23. Hwang ES, Locklear TD, Rushing CN, et al. Patient-reported outcomes after choice for contralateral prophylactic mastectomy. J Clin Oncol. 2016;34(13):1518–27.

    Article  Google Scholar 

  24. Mitchell A, Ferguson D, Gill J, Symonds P. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: A systematic review and meta-analysis. Lancet Oncol. 2013;34:721–32.

    Article  Google Scholar 

  25. Schmitz K, Speck R, Sheree A, et al. Prevalence of breast cancer treatment sequelae over 6 years of follow up, the pulling through study. Cancer. 2012;118(8):2217–25.

    Article  Google Scholar 

  26. Parker PA, Peterson SK, Shen Y, et al. Prospective study of psychosocial outcomes of having Contralateral prophylactic mastectomy among women with nonhereditary breast cancer. J Clin Oncol. 2018;36:2630–8. https://doi.org/10.1200/jco.2018.78.6442.

    Article  PubMed  Google Scholar 

  27. Rosenberg SM, Tracy MS, Meyer ME, et al. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer cross-sectional survey. Ann Intern Med. 2013;159(6):373–81. https://doi.org/10.7326/0003-4819-159-6-201309170-00003.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Frost MH, Scjhaid DJ, Sellers TA, et al. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA. 2000;284:319–24.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Medical University Graz, 8036, Graz, Austria

    Vesna Bjelic-Radisic MD, Karl Tamussino & Edgar Petru

  2. Breast Unit, Department of Obstetrics and Gynecology, Helios University Hospital, Wuppertal, University Witten/Herdecke, Heusnerstr. 40, 42283, Wuppertal, Germany

    Vesna Bjelic-Radisic MD

  3. Gynecological Oncology, Department of Gynaecology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria

    Christian Singer, Heinz Kölbl & Stephan Polterauer

  4. Department of Obstetrics and Gynecology, District Hospital Lienz, 9900, Lienz, Austria

    Birgit Volgger

  5. Department of Obstetrics and Gynecology, Medical University JKU Linz, 4040, Linz, Austria

    Peter Oppelt

  6. Department of Obstetrics and Gynecology, District Hospital Hietzing, 1130, Vienna, Austria

    Paul Sevelda

  7. Department of Obstetrics and Gynecology, Paracelsus Medical University Salzburg, 5020, Salzburg, Austria

    Gerhard Bogner

  8. Department of Obstetrics and Gynecology, Medical University Innsbruck, 6020, Innsbruck, Austria

    Christian Marth

Authors
  1. Vesna Bjelic-Radisic MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christian Singer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karl Tamussino
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Heinz Kölbl
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Edgar Petru
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Birgit Volgger
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stephan Polterauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Peter Oppelt
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Paul Sevelda
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Gerhard Bogner
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Christian Marth
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Austrian Gynecologic Oncology Working Group

Corresponding author

Correspondence to Vesna Bjelic-Radisic MD.

Ethics declarations

Conflict of interest

V. Bjelic-Radisic, C. Singer, K. Tamussino, H. Kölbl, E. Petru, B. Volgger, S. Polterauer, P. Oppelt, P. Sevelda, G. Bogner, and C. Marth declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bjelic-Radisic, V., Singer, C., Tamussino, K. et al. Contralateral prophylactic mastectomy in women with breast cancer without a family history or genetic predisposition. Wien Klin Wochenschr 131, 233–236 (2019). https://doi.org/10.1007/s00508-019-1468-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-019-1468-7

Keywords

Search

Navigation